We will also review common mistakes that can compromise the peptide and provide a clear disclaimer about its intended research-only use
Higher doses increase side effect risk without proportional benefit increases
In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support
Patients often stop thinking about food between meals, experience genuine disinterest in favorite snacks, and naturally reduce calorie intake by 5001000 calories per day without hunger or deprivation
Not just look" TikTok1.1M views @charliecaruso8's peptide workout claims, fact-checked @charliecaruso8 "This guy took peptides for 50 days to see what would happen